Search results
Pfizer to pay $25.5 mln to settle remaining Effexor XR antitrust claims
Reuters· 59 minutes agoPfizer has agreed to pay $25.5 million to resolve claims that its predecessor Wyeth conspired with...
Here's How to Play Pfizer (PFE) Stock Ahead of Q1 Earnings
Zacks via Yahoo Finance· 7 hours agoPfizer (PFE) expects its operational revenues to improve, driven by its in-line products like...
US FDA grants full approval for Pfizer's cervical cancer drug
AOL· 3 hours agoThe treatment, Tivdak - an antibody-drug conjugate co-developed by Genmab A/S and Seagen - received the FDA's accelerated approval for the same indication in 2021. It was added to Pfizer ...
Pfizer gene therapy made in NC gets FDA approval. It costs $3.5M per dose - Triangle Business...
The Business Journals· 1 day agoThe U.S. Food and Drug Administration has approved a gene therapy developed by Pfizer and...
These 3 High-Yield Stocks Have Been Growing Their Dividends Non-Stop, And Analysts Expect Their...
Benzinga via Yahoo Finance· 3 hours agoIncome-seeking investors are always on the lookout for reliable high-yield stocks with a history of...
Pfizer’s First Gene Therapy Gets Approval for Clotting Disorder
Bloomberg· 3 days agoPfizer Inc. won US approval for its first gene therapy, expanding into a promising field of medicine...
US FDA approves Pfizer's gene therapy for rare bleeding disorder
Reuters via AOL· 3 days ago(Reuters) -The U.S. Food and Drug Administration approved Pfizer's gene therapy for hemophilia B on...
Labcorp nets companion diagnostic approval for Pfizer’s hemophilia B gene therapy Beqvez
FierceBiotech· 5 hours agoThe FDA has bestowed a green light to a companion diagnostic forPfizer’s recently approved...
Is Pfizer Stock A Sell As Shares Hit An 11-Year Low Amid The Search For Its Next Big Break?
Investor's Business Daily· 5 days agoPfizer stock is trading near an 11-year low as the drugmaker looks for its next big break after...
Why Pfizer (PFE) is a Top Value Stock for the Long-Term
Zacks via Yahoo Finance· 9 hours agoWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the...